Francisco Velazquez

USPTO Granted Patents = 17 (Patent Applications = 3)

CIPO Patents = 1

EPO Patents = 10 (Patent Applications = 7)

Average Co-Inventor Count = 9.2

ph-index = 6

Forward Citations = 107(Granted Patents)

Company Filing History:

9 out of 2,405

Merck Sharp + Dohme Corp.

Southern Research Institute

where one patent can have more than one assignee

Years Active: 2008-2021

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11161819 - Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists (2021-11-02),

2. 11014940 - Thiazolidinone and oxazolidinone compounds and formulations (2021-05-25),

3. 9433621 - Substituted pyridine and pyrimidine derivatives and their use in treating viral infections (2016-09-06),

4. 9328138 - HCV NS3 protease inhibitors (2016-05-03),

5. 8987195 - HCV NS3 protease inhibitors (2015-03-24),

6. 8901139 - Tricyclic indole derivatives and methods of use thereof (2014-12-02),

7. 8697694 - Substituted pyridine and pyrimidine derivatives and their use in treating viral infections (2014-04-15),

8. 8614229 - Substituted indole derivatives and methods of use thereof (2013-12-24),

9. 8557848 - 4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections (2013-10-15),

10. 8546420 - 4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections (2013-10-01),

11. 8143305 - 2,3-substituted indole derivatives for treating viral infections (2012-03-27),

12. 8067379 - Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease (2011-11-29),

13. 7816326 - Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease (2010-10-19),

14. 7592419 - Macrocyclic inhibitors of hepatitis C virus NS3-serine protease (2009-09-22),

15. 7485625 - Inhibitors of hepatitis C virus NS3/NS4a serine protease (2009-02-03),

Title: The Innovative Mind of Francisco Velazquez: A Pioneer in Pharmaceutical Patents

Introduction: Francisco Velazquez, an accomplished inventor based in Clinton, NJ, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 17 patents, his work focuses on treating various medical conditions through innovative compounds. His dedication to research and development has led to groundbreaking inventions that hold promise for improved healthcare solutions.

Latest Patents: Velazquez's latest patents showcase his expertise in pharmaceutical innovation. One notable invention is related to substituted tetrahydroisoquinoline compounds, which serve as GPR120 agonists. This invention is particularly relevant for treating or preventing diabetes, hyperlipidemia, obesity, non-alcoholic steatohepatitis (NASH), and inflammation-related disorders. The compounds and their pharmaceutically acceptable salts are presented as effective treatments for these prevalent conditions.

Another significant patent involves thiazolidinone and oxazolidinone compounds. The invention details various compounds and their potential uses in treating diseases associated with an activated immune system, such as multiple sclerosis and psoriasis. These pharmaceutical compositions and formulations developed by Velazquez represent a pivotal advancement in addressing complex health challenges.

Career Highlights: Throughout his career, Francisco Velazquez has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Schering Corporation. His extensive experience in these organizations has equipped him with invaluable knowledge and skills necessary for driving innovation in drug development.

Collaborations: In his pursuit of novel medicines, Velazquez has collaborated with esteemed colleagues, including Srikanth Venkatraman and F. George Njoroge. These partnerships have fostered a collaborative environment that promotes the exchange of ideas and enhances the invention process, resulting in more effective pharmaceutical solutions.

Conclusion: Francisco Velazquez exemplifies the spirit of innovation and dedication within the pharmaceutical field. With his 17 patents, he continues to pave the way for advancements that have the potential to significantly improve healthcare outcomes. His contributions highlight the vital role of inventors in creating effective treatments for diseases and disorders, ensuring a healthier future for individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.